Selected research
Industry Research
Bioanalytical Testing Industry Research Report 2026
Market perspective
The global Bioanalytical Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioanalytical Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioanalytical Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioanalytical Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioanalytical Testing include Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions and WuXi AppTec, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioanalytical Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioanalytical Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioanalytical Testing Market by Company
Eurofins Scientific
Charles River
LabCorp
Altasciences
Intertek
Celerion
ACM Global Laboratories
Q2 Solutions
WuXi AppTec
SGS
Ardena
VTT
ICON
Simbec-Orion
Medpace
Frontage
Pharmaron
Veeda
GenScript
Sino Biological
Tigermed
Medicilon
Scinovo
Bioanalytical Testing Segment by Type
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Biomarkers
Biologics and Vaccines
Bioanalytical Testing Segment by Application
Clinical
Non-clinical
Bioanalytical Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioanalytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioanalytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioanalytical Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioanalytical Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecule Bioanalysis
- Large Molecule Bioanalysis
- Biomarkers
- Biologics and Vaccines
Applications
- Clinical
- Non-clinical
Companies covered
- Eurofins Scientific
- Charles River
- LabCorp
- Altasciences
- Intertek
- Celerion
- ACM Global Laboratories
- Q2 Solutions
- WuXi AppTec
- SGS
- Ardena
- VTT
- ICON
- Simbec-Orion
- Medpace
- Frontage
- Pharmaron
- Veeda
- GenScript
- Sino Biological
- Tigermed
- Medicilon
- Scinovo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioanalytical Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Small Molecule Bioanalysis
- 2.2.3 Large Molecule Bioanalysis
- 2.2.4 Biomarkers
- 2.2.5 Biologics and Vaccines
- 2.3 Bioanalytical Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical
- 2.3.3 Non-clinical
- 2.4 Assumptions and Limitations
3 Bioanalytical Testing Breakdown Data by Type
- 3.1 Global Bioanalytical Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Bioanalytical Testing Forecasted Market Size by Type (2027-2032)
4 Bioanalytical Testing Breakdown Data by Application
- 4.1 Global Bioanalytical Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Bioanalytical Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioanalytical Testing Market Perspective (2021-2032)
- 5.2 Global Bioanalytical Testing Growth Trends by Region
- 5.2.1 Global Bioanalytical Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioanalytical Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Bioanalytical Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Bioanalytical Testing Market Dynamics
- 5.3.1 Bioanalytical Testing Industry Trends
- 5.3.2 Bioanalytical Testing Market Drivers
- 5.3.3 Bioanalytical Testing Market Challenges
- 5.3.4 Bioanalytical Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioanalytical Testing Players by Revenue
- 6.1.1 Global Top Bioanalytical Testing Players by Revenue (2021-2026)
- 6.1.2 Global Bioanalytical Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioanalytical Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioanalytical Testing Head Office and Area Served
- 6.4 Global Bioanalytical Testing Players, Product Type & Application
- 6.5 Global Bioanalytical Testing Manufacturers Established Date
- 6.6 Global Bioanalytical Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioanalytical Testing Market Size (2021-2032)
- 7.2 North America Bioanalytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioanalytical Testing Market Size by Country (2021-2026)
- 7.4 North America Bioanalytical Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioanalytical Testing Market Size (2021-2032)
- 8.2 Europe Bioanalytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioanalytical Testing Market Size by Country (2021-2026)
- 8.4 Europe Bioanalytical Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioanalytical Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Bioanalytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioanalytical Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioanalytical Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioanalytical Testing Market Size (2021-2032)
- 10.2 South America Bioanalytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioanalytical Testing Market Size by Country (2021-2026)
- 10.4 South America Bioanalytical Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioanalytical Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Bioanalytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioanalytical Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioanalytical Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Bioanalytical Testing Business (2021-2026)
- 12.1.4 Eurofins Scientific Bioanalytical Testing Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Charles River
- 12.2.1 Charles River Company Information
- 12.2.2 Charles River Business Overview
- 12.2.3 Charles River Revenue in Bioanalytical Testing Business (2021-2026)
- 12.2.4 Charles River Bioanalytical Testing Product Portfolio
- 12.2.5 Charles River Recent Developments
- 12.3 LabCorp
- 12.3.1 LabCorp Company Information
- 12.3.2 LabCorp Business Overview
- 12.3.3 LabCorp Revenue in Bioanalytical Testing Business (2021-2026)
- 12.3.4 LabCorp Bioanalytical Testing Product Portfolio
- 12.3.5 LabCorp Recent Developments
- 12.4 Altasciences
- 12.4.1 Altasciences Company Information
- 12.4.2 Altasciences Business Overview
- 12.4.3 Altasciences Revenue in Bioanalytical Testing Business (2021-2026)
- 12.4.4 Altasciences Bioanalytical Testing Product Portfolio
- 12.4.5 Altasciences Recent Developments
- 12.5 Intertek
- 12.5.1 Intertek Company Information
- 12.5.2 Intertek Business Overview
- 12.5.3 Intertek Revenue in Bioanalytical Testing Business (2021-2026)
- 12.5.4 Intertek Bioanalytical Testing Product Portfolio
- 12.5.5 Intertek Recent Developments
- 12.6 Celerion
- 12.6.1 Celerion Company Information
- 12.6.2 Celerion Business Overview
- 12.6.3 Celerion Revenue in Bioanalytical Testing Business (2021-2026)
- 12.6.4 Celerion Bioanalytical Testing Product Portfolio
- 12.6.5 Celerion Recent Developments
- 12.7 ACM Global Laboratories
- 12.7.1 ACM Global Laboratories Company Information
- 12.7.2 ACM Global Laboratories Business Overview
- 12.7.3 ACM Global Laboratories Revenue in Bioanalytical Testing Business (2021-2026)
- 12.7.4 ACM Global Laboratories Bioanalytical Testing Product Portfolio
- 12.7.5 ACM Global Laboratories Recent Developments
- 12.8 Q2 Solutions
- 12.8.1 Q2 Solutions Company Information
- 12.8.2 Q2 Solutions Business Overview
- 12.8.3 Q2 Solutions Revenue in Bioanalytical Testing Business (2021-2026)
- 12.8.4 Q2 Solutions Bioanalytical Testing Product Portfolio
- 12.8.5 Q2 Solutions Recent Developments
- 12.9 WuXi AppTec
- 12.9.1 WuXi AppTec Company Information
- 12.9.2 WuXi AppTec Business Overview
- 12.9.3 WuXi AppTec Revenue in Bioanalytical Testing Business (2021-2026)
- 12.9.4 WuXi AppTec Bioanalytical Testing Product Portfolio
- 12.9.5 WuXi AppTec Recent Developments
- 12.10 SGS
- 12.10.1 SGS Company Information
- 12.10.2 SGS Business Overview
- 12.10.3 SGS Revenue in Bioanalytical Testing Business (2021-2026)
- 12.10.4 SGS Bioanalytical Testing Product Portfolio
- 12.10.5 SGS Recent Developments
- 12.11 Ardena
- 12.11.1 Ardena Company Information
- 12.11.2 Ardena Business Overview
- 12.11.3 Ardena Revenue in Bioanalytical Testing Business (2021-2026)
- 12.11.4 Ardena Bioanalytical Testing Product Portfolio
- 12.11.5 Ardena Recent Developments
- 12.12 VTT
- 12.12.1 VTT Company Information
- 12.12.2 VTT Business Overview
- 12.12.3 VTT Revenue in Bioanalytical Testing Business (2021-2026)
- 12.12.4 VTT Bioanalytical Testing Product Portfolio
- 12.12.5 VTT Recent Developments
- 12.13 ICON
- 12.13.1 ICON Company Information
- 12.13.2 ICON Business Overview
- 12.13.3 ICON Revenue in Bioanalytical Testing Business (2021-2026)
- 12.13.4 ICON Bioanalytical Testing Product Portfolio
- 12.13.5 ICON Recent Developments
- 12.14 Simbec-Orion
- 12.14.1 Simbec-Orion Company Information
- 12.14.2 Simbec-Orion Business Overview
- 12.14.3 Simbec-Orion Revenue in Bioanalytical Testing Business (2021-2026)
- 12.14.4 Simbec-Orion Bioanalytical Testing Product Portfolio
- 12.14.5 Simbec-Orion Recent Developments
- 12.15 Medpace
- 12.15.1 Medpace Company Information
- 12.15.2 Medpace Business Overview
- 12.15.3 Medpace Revenue in Bioanalytical Testing Business (2021-2026)
- 12.15.4 Medpace Bioanalytical Testing Product Portfolio
- 12.15.5 Medpace Recent Developments
- 12.16 Frontage
- 12.16.1 Frontage Company Information
- 12.16.2 Frontage Business Overview
- 12.16.3 Frontage Revenue in Bioanalytical Testing Business (2021-2026)
- 12.16.4 Frontage Bioanalytical Testing Product Portfolio
- 12.16.5 Frontage Recent Developments
- 12.17 Pharmaron
- 12.17.1 Pharmaron Company Information
- 12.17.2 Pharmaron Business Overview
- 12.17.3 Pharmaron Revenue in Bioanalytical Testing Business (2021-2026)
- 12.17.4 Pharmaron Bioanalytical Testing Product Portfolio
- 12.17.5 Pharmaron Recent Developments
- 12.18 Veeda
- 12.18.1 Veeda Company Information
- 12.18.2 Veeda Business Overview
- 12.18.3 Veeda Revenue in Bioanalytical Testing Business (2021-2026)
- 12.18.4 Veeda Bioanalytical Testing Product Portfolio
- 12.18.5 Veeda Recent Developments
- 12.19 GenScript
- 12.19.1 GenScript Company Information
- 12.19.2 GenScript Business Overview
- 12.19.3 GenScript Revenue in Bioanalytical Testing Business (2021-2026)
- 12.19.4 GenScript Bioanalytical Testing Product Portfolio
- 12.19.5 GenScript Recent Developments
- 12.20 Sino Biological
- 12.20.1 Sino Biological Company Information
- 12.20.2 Sino Biological Business Overview
- 12.20.3 Sino Biological Revenue in Bioanalytical Testing Business (2021-2026)
- 12.20.4 Sino Biological Bioanalytical Testing Product Portfolio
- 12.20.5 Sino Biological Recent Developments
- 12.21 Tigermed
- 12.21.1 Tigermed Company Information
- 12.21.2 Tigermed Business Overview
- 12.21.3 Tigermed Revenue in Bioanalytical Testing Business (2021-2026)
- 12.21.4 Tigermed Bioanalytical Testing Product Portfolio
- 12.21.5 Tigermed Recent Developments
- 12.22 Medicilon
- 12.22.1 Medicilon Company Information
- 12.22.2 Medicilon Business Overview
- 12.22.3 Medicilon Revenue in Bioanalytical Testing Business (2021-2026)
- 12.22.4 Medicilon Bioanalytical Testing Product Portfolio
- 12.22.5 Medicilon Recent Developments
- 12.23 Scinovo
- 12.23.1 Scinovo Company Information
- 12.23.2 Scinovo Business Overview
- 12.23.3 Scinovo Revenue in Bioanalytical Testing Business (2021-2026)
- 12.23.4 Scinovo Bioanalytical Testing Product Portfolio
- 12.23.5 Scinovo Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst